MPS I or Mucopolysaccharidosis type I (see NIH description) is a rare genetic disorder. About 1 in 500,000 are diagnosed with attenuated MPS I. Sangamo, a publicly traded Bay Area venture, announced that the first patient was treated in “The EMPOWERS study, an...